Tay-Sachs disease research

Tay-Sachs disease research

Give online
to Tay-Sachs disease research

  • MR scanning images showing severe brain injury in a young girl with Tay-Sachs disease
    MRI showing severe brain injury in a young girl with Tay-Sachs disease

Tay-Sachs disease is a rare and usually fatal genetic disorder, which causes progressive damage to the nervous system. Research conducted at the University of Cambridge (and by collaborators in Alabama) has shown that it is possible to cure this condition by gene therapy.

Tay-Sachs disease is a notorious killer which has been known for about 140 years. Although it is inherited, the child is born completely normal and it is only after a few months that something wrong is noted. The child becomes floppy and passive, sight is impaired and eventually convulsions or seizures (fits) occur. Alarmingly, there is a rapid loss of all faculties, so the baby cannot even feed itself and often chokes. Without the help of a feeding tube, babies with Tay-Sachs disease often die in the first year or two of life.

By introducing a normal copy of the affected gene (to supplement the activity of the genes that are slightly altered and inherited from carrier parents) into parts of the brain, we can have a widespread effect in correcting the abnormalities. Indeed, in experimental systems, if this gene therapy is given before serious manifestations have occurred, life is prolonged and neurological function is preserved.

Make a donation

Make a gift now

To make a gift to Medicine - Cox Group Tay-Sachs disease research using a credit or debit card

Give online

Find out about other ways to give.

 

Find out more

Tay-Sachs disease research website

Related gift announcements

Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.

Gift announcement
A leading multidisciplinary think tank, the PHG Foundation, will become part of the University of Cambridge from 1 April this year, with a focus on making science work for health. This has been made possible by a philanthropic gift from the Hong Kong-based Hatton Trust, which has recognised the University’s global eminence in science, medicine and the humanities alongside the pioneering policy development work of the Foundation.
A laboratory scientist
Gift announcement
Established as a charity in 1920, the Evelyn Trust makes grants to support medical research and health and wellbeing projects in Cambridgeshire. The Trust is particularly interested in research projects that have the potential to deliver transformational change, such as demonstration or pilot projects.

Related impact stories

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students received an unrivalled education.

Illustration of a nerve cell
Philanthropic impact story
The recently-launched Milner Therapeutics Institute and Consortium aims to tackle some of today’s most globally devastating diseases, including cancer and Alzheimer’s.
The new Laboratory of Molecular Biology at Addenbrooke's hospital
Philanthropic impact story
At any one time, more than 1000 clinical trials are being conducted across the Cambridge Biomedical Campus, the largest gathering of clinical, pharmaceutical and biomedical research specialists in Europe. These trials are a crucial step in the design of new medicines and medical devices – translating ideas that started in a research laboratory into new treatments for patients.